AAAAAA

   
Results: 1-4 |
Results: 4
ON MYOCARDIAL PERFUSION, METABOLISM, AND VIABILITY
Authors: HANSEN CL RASTOGI A SANGRIGOLI R
Citation: Cl. Hansen et al., ON MYOCARDIAL PERFUSION, METABOLISM, AND VIABILITY, Journal of nuclear cardiology, 5(2), 1998, pp. 202-205
ALTERED MYOCARDIAL EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA AFTER MECHANICAL SUPPORT IN PATIENTS WITH SEVERE IDIOPATHIC DILATED CARDIOMYOPATHY
Authors: SANGRIGOLI R BELLAND SE BERNABEI M TORRES J GOLDMAN B JEEVANANDAM V EISEN HJ
Citation: R. Sangrigoli et al., ALTERED MYOCARDIAL EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA AFTER MECHANICAL SUPPORT IN PATIENTS WITH SEVERE IDIOPATHIC DILATED CARDIOMYOPATHY, Journal of the American College of Cardiology, 29(2), 1997, pp. 8042-8042
FAILURE OF CARDIAC TRANSPLANT RECIPIENTS TO DEVELOP HUMORAL IMMUNE-RESPONSES TO STANDARD HEPATITIS-B VACCINATION
Authors: SANGRIGOLI R MCCARTHY D ROURKE T WASHINGTON R EISEN HJ
Citation: R. Sangrigoli et al., FAILURE OF CARDIAC TRANSPLANT RECIPIENTS TO DEVELOP HUMORAL IMMUNE-RESPONSES TO STANDARD HEPATITIS-B VACCINATION, Circulation, 96(8), 1997, pp. 2059-2059
CONCURRENT LIPID-LOWERING THERAPY WITH HMG-COA REDUCTASE INHIBITORS REDUCES THE INCIDENCE OF ISHLT GRADES 3A AND 3B REJECTION IN CARDIAC TRANSPLANT RECIPIENTS
Authors: SANGRIGOLI R EISEN HJ
Citation: R. Sangrigoli et Hj. Eisen, CONCURRENT LIPID-LOWERING THERAPY WITH HMG-COA REDUCTASE INHIBITORS REDUCES THE INCIDENCE OF ISHLT GRADES 3A AND 3B REJECTION IN CARDIAC TRANSPLANT RECIPIENTS, Circulation, 96(8), 1997, pp. 2061-2061
Risultati: 1-4 |